AZ is also developing a rival triple therapy inhaler, Breztri Aerosphere (budesonide+glycopyrrolate+formoterol fumarate), which is already approved in the US in COPD and is in late-stage ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...

I expect AstraZeneca's revenue to continue to grow in the coming years, driven mainly by rising demand for Ultomiris, Strensiq, Farxiga, Imfinzi, Lokelma, Breztri, and regulatory approvals of its ...

After hours: 24 January at 7:57:32 pm GMT-5 ...